Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cavazzoni

Showing results (241-250 of 308) with videos related to

Pageof 31
Sort By:
Frontiers in Oncology|August 8, 2022
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cellsGraziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2021
Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantationMostafa T Mohammed, Songjie Cai, Benjamin L Hanson, et al.
Cells|September 9, 2022
Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the ClinicsRita Balsano, Zita Kruize, Martina Lunardi, et al.
Journal of Medicinal Chemistry|February 16, 2010
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portionCaterina Carmi, Andrea Cavazzoni, Stefano Vezzosi, et al.
Cancers|April 26, 2025
Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. <i>Cancers</i> 2020, <i>12</i>, 666Andrea Cavazzoni, Graziana Digiacomo, Roberta Alfieri, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 16, 2018
Acceptability, effectiveness and safety of a RenewJ P Segal, C A Leo, J D Hodgkinson, et al.
European Journal of Medicinal Chemistry|November 26, 2018
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFRRiccardo Castelli, Nicole Bozza, Andrea Cavazzoni, et al.
Biochemical Pharmacology|June 29, 2024
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatmentsClaudia Fumarola, Silvia La Monica, Mara Bonelli, et al.
Plos One|November 5, 2015
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell LinesMaricla Galetti, Pier Giorgio Petronini, Claudia Fumarola, et al.
Nature Immunology|January 31, 2025
Progressively differentiated T<sub>FH</sub>13 cells are stabilized by JunB to mediate allergen germinal center responsesPragya Chandrakar, Cody S Nelson, Manuel A Podestà, et al.
Pageof 31

Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
Frontiers in Oncology|August 8, 2022
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cellsGraziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2021
Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantationMostafa T Mohammed, Songjie Cai, Benjamin L Hanson, et al.
Cells|September 9, 2022
Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the ClinicsRita Balsano, Zita Kruize, Martina Lunardi, et al.
Journal of Medicinal Chemistry|February 16, 2010
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portionCaterina Carmi, Andrea Cavazzoni, Stefano Vezzosi, et al.
Cancers|April 26, 2025
Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. <i>Cancers</i> 2020, <i>12</i>, 666Andrea Cavazzoni, Graziana Digiacomo, Roberta Alfieri, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 16, 2018
Acceptability, effectiveness and safety of a RenewJ P Segal, C A Leo, J D Hodgkinson, et al.
European Journal of Medicinal Chemistry|November 26, 2018
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFRRiccardo Castelli, Nicole Bozza, Andrea Cavazzoni, et al.
Biochemical Pharmacology|June 29, 2024
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatmentsClaudia Fumarola, Silvia La Monica, Mara Bonelli, et al.
Plos One|November 5, 2015
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell LinesMaricla Galetti, Pier Giorgio Petronini, Claudia Fumarola, et al.
Nature Immunology|January 31, 2025
Progressively differentiated T<sub>FH</sub>13 cells are stabilized by JunB to mediate allergen germinal center responsesPragya Chandrakar, Cody S Nelson, Manuel A Podestà, et al.
Pageof 31